| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 10 Nov 2026 |
Form 4: Bye Stephen J, Director
Bought 12,500 shares ($138K) |
| 10 Nov 2026 |
Form 4: Gavales Lisa A, Director
Bought 5,000 shares ($55.1K) |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Revenue of $153 million; Clinical Subscription Revenue of $38 million, up 48% year-over-year |
| 13 Oct 2026 | SCHEDULE 13G/A |
| 05 Oct 2026 |
Form 4: Bye Stephen J, Director
Granted 63,134 Restricted Stock Unit |
| 01 Oct 2026 |
Form 3: Bye Stephen J, Director
No securities owned |
| 21 Sep 2026 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On September 9, 2026, WW International, Inc. (the “Company”) filed a Current Report on Form 8-K to (i) announce the appointment of Stephen J. Bye as President and Chief Executive Officer and as a director of the Company’s Board of Direct... |
| 09 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
On behalf of WW International, Inc. (the “Company”), I am pleased to offer you the position of President and Chief Executive Officer of the Company on the terms and conditions set forth in this letter agreement (this “Agreement”). Capita... |
| 26 Aug 2026 | SCHEDULE 13G/A |
| 20 Aug 2026 |
Form 4: Sjoqvist Nikolaj H, Director
Bought 7,235 shares ($100K) |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 |
Form 4: Gove Sue, Director
Granted 8,132 Restricted Stock Unit |
| 12 Aug 2026 |
Form 4: Sjoqvist Nikolaj H, Director
Granted 8,132 Restricted Stock Unit |
| 12 Aug 2026 |
Form 4: Davis Eugene I, Director
Granted 8,132 Restricted Stock Unit |
| 12 Aug 2026 |
Form 4: Gavales Lisa A, Director
Granted 8,132 Restricted Stock Unit |
| 12 Aug 2026 |
Form 4: Hawks Carney, Director
Granted 8,132 Restricted Stock Unit |
Loading...